A detailed history of Aqr Arbitrage LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Aqr Arbitrage LLC holds 512,091 shares of CTLT stock, worth $32.5 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
512,091
Previous 358,167 42.98%
Holding current value
$32.5 Million
Previous $20.1 Million 54.01%
% of portfolio
1.47%
Previous 1.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $8.64 Million - $9.38 Million
153,924 Added 42.98%
512,091 $31 Million
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $9.45 Million - $10.1 Million
-176,379 Reduced 33.0%
358,167 $20.1 Million
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $22.8 Million - $32 Million
534,546 New
534,546 $30.2 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Aqr Arbitrage LLC Portfolio

Follow Aqr Arbitrage LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Arbitrage LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Arbitrage LLC with notifications on news.